PKM and Alzheimer disease: They showed that this vicious loop exacerbated glucose metabolism disorder and pro-inflammatory activation of microglia in AD, while breakdown of this loop could curb the development of AD pathology and cognitive decline, suggesting that inhibiting glycolysis/H4K12 lactylation/PKM2 loop in microglia is a potential therapeutic strategy for the treatment of AD.